Literature DB >> 22310302

Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients.

Dieter Hoffmann1, Martin Hutzenthaler, Judith Seebach, Marcus Panning, Andreas Umgelter, Helge Menzel, Ulrike Protzer, Dirk Metzler.   

Abstract

Norovirus has become an important cause for infectious gastroenteritis. Particularly genotype II.4 (GII.4) has been shown to spread rapidly and causes worldwide pandemics. Emerging new strains evade population immunity and lead to high norovirus prevalence. Chronic infections have been described recently and will become more prevalent with increasing numbers of immunocompromized patients. Here, we studied norovirus evolution in three chronically infected patients, two genotypes II.4 and one II.7. A 719 and 757 nt region was analyzed for GII.4 and GII.7, respectively. This covers the entire hypervariable P2 domain of the VP1 capsid gene. Genetic variability at given and between different time points was assessed. Evolutionary adaptation was analyzed by Bayesian sampling of genealogies. This analysis clearly demonstrated positive selection rather than incidental drift for all three strains. The GII.7 and one GII.4 strain accumulated on average 5-9 mutations per 100 days, most of them non-synonymous. This is a much higher evolutionary rate than observed for noroviruses on a global level. Our data demonstrate that norovirus quasispecies are positively selected in chronically infected patients. The numbers of intraindividual amino acid mutations acquired in the capsid gene are similar to those separating consecutive GII.4 epidemic strains. Evolution in a given, chronically infected individual may thus generate novel genotypes at risk to expedite global evolution particularly for slowly evolving genotypes, as GII.7.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310302     DOI: 10.1016/j.meegid.2012.01.020

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  19 in total

Review 1.  What is the reservoir of emergent human norovirus strains?

Authors:  Stephanie M Karst; Ralph S Baric
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

Review 2.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Chronic norovirus infection in a patient with a past history of Burkitt lymphoma.

Authors:  Leesa D Bruggink; Lachlan Hayes; John A Marshall
Journal:  Virusdisease       Date:  2015-08-20

4.  RNA populations in immunocompromised patients as reservoirs for novel norovirus variants.

Authors:  Everardo Vega; Eric Donaldson; Jeremy Huynh; Leslie Barclay; Ben Lopman; Ralph Baric; Luke F Chen; Jan Vinjé
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation.

Authors:  Ulrike Protzer; Friederike Böhm; Thomas Longerich; Judith Seebach; Mojdeh Heidary Navid; Juliane Friemel; Ewerton Marques-Maggio; Marion Bawohl; Mathias Heikenwalder; Peter Schirmacher; Philipp Dutkowski; Pierre-Alain Clavien; Peter Schemmer; Paul Schnitzler; Daniel Gotthardt; Beat Müllhaupt; Achim Weber
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

6.  Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.

Authors:  Vesselin T Tomov; Lisa C Osborne; Douglas V Dolfi; Gregory F Sonnenberg; Laurel A Monticelli; Kathleen Mansfield; Herbert W Virgin; David Artis; E John Wherry
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 7.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

8.  Norovirus gastroenteritis in immunocompromised patients.

Authors:  Sarah Haessler; Eric V Granowitz
Journal:  N Engl J Med       Date:  2013-03-07       Impact factor: 91.245

9.  Within-host evolution results in antigenically distinct GII.4 noroviruses.

Authors:  Kari Debbink; Lisa C Lindesmith; Martin T Ferris; Jesica Swanstrom; Martina Beltramello; Davide Corti; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

Review 10.  Norovirus gastroenteritis in immunocompromised patients.

Authors:  Karin Bok; Kim Y Green
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.